EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al > Summary
Court Case Number 1:21-cv-20723
Filing Date Dec 27, 2021
Termination Date Jun 9, 2022
Court New Jersey District Court
Status Dismissed - Settled
Plaintiff Attorneys
11Eisai Co., Ltd.
Attorney Name: William P. Deni Jr.
Gibbons P.C.
Eisai Co., Ltd.
Attorney Name: Jonathon Brugh Lower
Gibbons P.C.
NOVARTIS PHARMA AG
Attorney Name: William P. Deni Jr.
Gibbons P.C.
NOVARTIS PHARMA AG
Attorney Name: Jonathon Brugh Lower
Gibbons P.C.
Eisai Co., Ltd.
Attorney Name: William P. Deni Jr.
Eisai Co., Ltd.
Attorney Name: Jonathon Brugh Lower
Eisai Co., Ltd.
Attorney Name: William P. Deni Jr.
Eisai Co., Ltd.
Attorney Name: Jonathon Brugh Lower
NOVARTIS PHARMA AG
Attorney Name: William P. Deni Jr.
NOVARTIS PHARMA AG
Attorney Name: Jonathon Brugh Lower
Attorney Name: Jonathon Brugh Lower
Defendant Attorneys
2Aurobindo Pharma
Attorney Name: R. Touhey Myer
Aurobindo Pharma USA
Attorney Name: R. Touhey Myer
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 06740669 | Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic | May 25, 2004 |
